Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
28.00
-0.93 (-3.21%)
At close: Jan 8, 2026, 4:00 PM EST
27.98
-0.02 (-0.08%)
After-hours: Jan 8, 2026, 7:48 PM EST
Beam Therapeutics Employees
Beam Therapeutics had 483 employees as of December 31, 2024. The number of employees increased by 47 or 10.78% compared to the previous year.
Employees
483
Change (1Y)
47
Growth (1Y)
10.78%
Revenue / Employee
$115,323
Profits / Employee
-$858,474
Market Cap
2.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 483 | 47 | 10.78% |
| Dec 31, 2023 | 436 | -71 | -14.00% |
| Dec 31, 2022 | 507 | 166 | 48.68% |
| Dec 31, 2021 | 341 | 160 | 88.40% |
| Dec 31, 2020 | 181 | 63 | 53.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BEAM News
- 21 days ago - Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal - Seeking Alpha
- 2 months ago - Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates - GlobeNewsWire
- 2 months ago - Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 2 months ago - Beam Therapeutics: SCD Catalysts Have Untapped Upside Potential - Seeking Alpha
- 4 months ago - Beam Therapeutics Inc. (BEAM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) - Seeking Alpha